Www.hippocrateon.com



CV-COMPR, GEORGE MARCOULLIS, MD, PhD(Revised: 6.7.2019)NAME: George P. Marcoullis, M.D., PhD (ScD).MAILING ADDRESS: Hippocrateon Private Hospital, 6-12 Psaron Str., P.O.Box 27509, 2408 Engomi,Nicosia, CyprusBUSINESS ADDRESSES: Hippocrateon Private Hospital, 6-12 Psaron Str., P.O.Box 27509, 2408 Engomi, Nicosia, CyprusHOME ADDRESS: 12 Kasos Street, Apt 121, Building THETA, 1086 Ayioi Omoloyites, Nicosia, CyprusTELEPHONE: (357) 22 502 286 (W, Hippo.) (357) 99 097 427 (Cell) (357) 22 502 299 (Fax, Hippo.)(357) 22 519 342 (Fax, H)(357) 22 519 342 (H)E MAIL: gmarcoullis@.cy, WEBSITE: MARITAL & FAMILY STATUS: Married to Erato Kozakou-Marcoullis; Formerly, Minister of Foreign Affairs; Previously, Minister of Transportation, Communications and Works of the Republic of Cyprus; one son (Panos Marcoullis, MS, Information Systems Technologies; MS, Project management; Currently: Owner of Hellenica-Marcoullis LLC)PRESENT POSITIONSProfessor of Medicine, Saint George’s University of London Medical Program at University of Nicosia (UNIC) and UNIC-Academic Lead at Hippocrateon Private Hospital, Nicosia, 2016-Head, Haematology/Oncology/Chemotherapy Units: Hippocrateon Private Hospital, Nicosia, Cyprus, December 2005 –EDUCATION & TRAININGCertification in: Medicine and Surgery, University of the State of New York, February 1985Certification by: Educational Commission for Foreign Medical Graduates, USA, February 1983Medical Dissertation (Summa Cum Laude): Degree (PhD) and Title of Doctor of Sciences (ScD), Helsinki University School of Medicine, Finland, September 1978Degree of Graduation in Medicine-MD (Magna Cum Laude), Athens University School of Medicine, Greece, October 1974Certification of Graduation, Limassol Lanition Gymnasium-for Boys (Practical-Sciences Section), July 1967Certification of Graduation (Magna Cum Laude), IV Elementary School of Limassol, June 1961ACADEMIC & PROFESSIONAL RECORDS (also see ‘Present Positions’, above)Acting Dean, School of Medicine, European University Cyprus, September 2013 - July 2016Professor of Medicine, School of Medicine, European University Cyprus, June 2010 - July 2016 Chairman, Preparatory Committee for the Development of the School of Medicine at the European University of Cyprus, June 2010 - September 2013Dean, School of Health Sciences and Professor of Medicine, Frederick University Cyprus (February 2008 – May 2010) & Frederick Institute of Technology (April 2007 – December 2007)Consultant in Haematology/Oncology, The Regional Cancer Centre; Erie, Pennsylvania, September 2004 - December 2005Associate Professor of Medicine, New York Medical College, November 2000 - October 2004Director, Bone Marrow and Blood Stem Cell Transplantation Unit, Comprehensive Cancer Centre at Our Lady of Mercy Medical Centre, September 2002 - September 2004Attending Medical Oncologist/Haematologist, Comprehensive Cancer Centre at Our Lady of Mercy Medical Centre, September 1999 - October 2004National Institutes of Health, USA: Sabbatical on Allogeneic Stem Cell Transplantation, June - October, 2002Director, Haematology Oncology Centre, September 1993 - September 1999, Nicosia, CyprusAssociate Professor of Medicine (Adjunct), New York Medical College, 1991 - 1994Director, Haematology Section and Co-director of the Centre, Mediterranean Oncology Radiotherapy Haematology Centre, Nicosia, Cyprus, January 1989 - September 1993Associate Professor of Medicine, New York, Medical College, 1984 - 1991Fellow in Bone Marrow Transplantation/Medical Oncology, Montefiore Medical Centre/Albert Einstein Cancer Centre, May - December 1991Director, Beebe Hospital, Haematology/Oncology Sections, Lewes Delaware, July 1987 – December 1988Research Associate Professor of Medicine, State University of New York, Downstate Centre, 1980 - 1983Visiting Associate Professor of Biochemistry, Nancy University Faculty of Sciences, France, 1981Visiting Professor of Medicine, Nancy University Faculty of Medicine, France, 1979 - 1980Research Assistant Professor of Medicine, New York Medical College, 1977 - 1980 Medical Investigator (1975-1977) and Junior Investigator (1973 – 1975), Minerva Foundation Institute, FinlandJunior Investigator, Department of Experimental Pharmacology, National University of Athens, 1971 - 1973POST-GRADUATE TRAININGJuly 1986 – June 1987: Haematology/Oncology Fellowship, Albert Einstein College of MedicineJuly 1984 – June 1986: Haematology/Oncology Fellowship, Westchester County Medical Centre/New York Medical CollegeJuly 1983 – June 1984: Medical Residency (Chief Medical Resident), Mount Vernon Hospital & New York Medical College Affiliated HospitalsMarch 1983 – June 1983: Medical Residency, Veterans Administration Hospital, Washington DCAugust 1982 – November 1982: Medical Residency, Department of Gastroenterology Hospital Brabois, Centre Hospitalier Universite de Nancy, FranceJanuary 1976 – March 1977: Medical Residency, Department of Clinical and Nuclear Medicine “Maaria” Public Health Centre, FinlandBOARD CERTIFICATIONSCertification in Medical Oncology: Medical Council, Cyprus, January 2006American Board of Internal Medicine, Certification in Medical Oncology, November 2002European Society of Medical Oncology, Certification in Medical Oncology, November 1992American Board of Internal Medicine: Certification in Internal Medicine, September 1987Certification in Haematology: Medical Council, Cyprus, May 1986Federation Licensing (FLEX), Medical Board, State of New York: Certification, December 1983Educational Commission for Foreign Medical Graduates, Certification (ECFMG): July 1982 HONORS, AWARDS, GRANTS & PATENTSInstitut National de la Propriete Industrielle, France, Patent No 81 213 48: George Marcoullis, Jean-Pierre Nicolas: Radioimmunoassay for Exocrine Pancreatic Insufficiency, 1985Principal Investigator, Merit Review Boards of Veterans Administration, USA: “Structure and Function of Receptor Proteins for Cobalamin in Ileal Cells”, Funded for 1983-1986Co-Principal Investigator (N.I.H., USA, Grant #2 R01 AM 06045-6): “Kinetics of Vitamin B12, Intrinsic Factor and Other Proteins”, 1979 -1984Medal Award of the University of Nancy to Eminent-Scientists: Medical Faculty, University of Nancy, France, 1980I.N.S.E.R.M-Visiting Professor of Medicine (Decision No. 79-659-DPG-E-GW-AP), University of Nancy, France, 1979-1980I.N.S.E.R.M-Visiting Professor of Biochemistry (Decision No. DAP 11-VL/MT-No 701), University of Nancy, France, 1985-86The 1979-Prize and Award of the University of Nancy to Foreign Investigators: For work performed: Studies explaining the impaired vitamin B-12 absorption in exocrine pancreatic insufficiency; Medical Faculty, University of Nancy, July 1979Awards from I.N.S.E.R.M. (National Institutes of Health, France) to Outstanding Foreign Medical Investigators: Institut National de la Sante et de la Recherché medicale, France 1977, 1978, 1979Awards from World Health Organization: For studies on Filarial Antigens, 1975, 1976, 1977Awards from the Minerva Institute to Junior Investigators: Minerva Foundation Institute for Medical Research, Finland 1973 and 1975Awards and Scholarships from Athens University: Awarded to the outstanding graduate of all Medical Faculties of Greece, National University of Athens 1971, 1972, 1973 and 1974SECONDARY, INSTITUTIONAL & SUBORDINATE RESEARCH FUNDINGResearch Promotion Foundation, Cyprus: CYMediNet: Pancyprian Information System for Interlinking and Administration of Medical Centers , Cyprus Medical Network, 2009-2011Sigrid Juselius Foundation (Finland), for work performed: Solubilized Intrinsic Factor Receptors,1975 - 1977; Isolation of Vitamin B12-Binding Proteins, 1977; Intrinsic Factor and Cobalophilin, 1978Livoch Halsa Foundation (Finland), for work performed: Solubilized Intrinsic Factor Receptors, 1975-1977; Isolation of Vitamin B12-Binding Proteins, 1975 - 1977Nordisk Insulinfond (Finland), for work performed: Solubilized Intrinsic Factor Receptors, 1975-1977;Intrinsic Factor and Cobalophilin, 197 5- 1978Institut Nationale de la Sante et de la Recherche Medicale (France) (Contract No 78.1249.7), for work performed: The Interaction of Cobalamin in the Gastrointestinal Tract, 1979, 1983Societas Scientiarum Fennica (Finland), for work performed: Antigens from Onchocerca volvulus, 1976National Institutes of Health, (USA) (AM 06045), for work performed: Preparation and Characterization of Cobalamin and Intrinsic Factor Binding Proteins in the Intestine; Intestinal Absorption of Cobalamin 1977 - 1981National Institutes of Health, (USA) (AM 28561), for work performed: Radioimmunoassay for Cyanocobalamin; Isolation and Characterization of Intrinsic Factor Receptors; Functional Radioassay for Intrinsic Factor Using IF-Receptor Protein, 1978-1984Mission de la Recherche, Ministere de l’Education (France), for work performed: Radioimmunoassay for Assessing Exocrine Pancreatic Insufficiency, 1984 - 1986C.E.R.B.A. (France): The role of Pancreatic Enzymes in the Intraluminal Transport and Ileal Absorption of Vitamin B12, 1979 - 1980D.G.R.S.T., (France) (No 77-7-0471), for work performed: Autoantibodies in Pernicious Ane mia Sera,1978; Vitamin B12-Transport Proteins and Pancreatic Insufficiency, 1979Etablissement Public Regional de Lorraine (France): The Interaction of Cobalamin in the Gastrointestinal Tract, 1983SERVICECyprus Health Journal, Editorial Board, 2010Cancer Investigation, Reviewer, 2002European Society of Medical Oncology, National Representatives’ Committee, Board Member: 1992 -1999; Re-elected, January 2006 - 2013Project Director: Planning, Fund Raising and Development of a “Day Center for Cancer Patients” in Cyprus, 1996 – 1998Cancer Society of Cyprus, Board of Directors-member, 1991 – 1998Cyprus Anti-Cancer Society, Medical Committee-member, November 2005- 2010Cyprus Society of Oncology, Vice President, April 2007 – 2009Υπουργε?ο Υγε?α? Κ?πρου: Μ?λο? Συμβουλευτικ?? ?Επιτροπ?? για αξιολ?γηση των αιτ?σεων για ?κδοση Εθνικ?? Υποστηρικτικ?? Επιστολ?? για σκοπο?? ?νταξη? σε Ευρωπα?κ? Δ?κτυα Αναφορ???, 2016?Επιτροπ? Ιατρικ?ν Σχολ?ν και Ακαδημα?κ?ν Θεμ?των ΠΙΣ?, ιδρυτικ? μ?λο?, 24 Μαρτ?ου, 2016?? ?νωση Κοσμητ?ρων Ιατρικ?ν Σχολ?ν Κ?πρου? (ΕΝΚΙΣΚ), ιδρυτικ? μ?λο?, 15 Σεπτεμβρ?ου 2015MEDICAL SOCIETIES:American Federation for Clinical Research, 1980Society for Experimental Biology and Medicine, 1981American College for Physicians, 1984The New York Academy of Sciences, 1985European Society of Medical Oncology, 1991American Society of Clinical Oncology, 1991Society for the Study of Blood, New York, 2000Hellenic Medical Society, New York, 2001American Society of Hematology, 2002American Society of Blood and Marrow Transplantation, 2002Cyprus Society of Oncology, 2005Cyprus Society of Hematology, 2008European Hematology Association, 2013ADIVISORY BOARDS & DISCLOSURESCatholic Palliative Care Network of New York, 2000Orphan Medical Advisory Board Meeting, March 16, 2000Merck, National Oncology Consultants Meeting, October 5-8, 2000Aventis, Regional Advisory Board Meeting, January 13-14, 2000Pharmacia Oncology Breast Cancer Investigators Meeting, May 11, 2001Cell Pathways, Investigators Meeting, May 13, 2001Immunex Corp. Consultants Meeting on Lymphoma Treatment, April 13, 2002Merck, Advisory Board Meeting, June 8-9, 2002Aventis, Advisory Board Meeting, September 14-15, 2002Merck, Advisory Board Meeting, October 18-19, 2002Aventis Prostate Cancer Consultants Meeting, April 23, 2003Aventis Prostate Cancer Consultants Meeting, June 18-19, 2004Cell Therapeutics/Arsenic Trioxide Regional Advisory Board Meeting, October 21, 2004Ortho Biotech Oncologist Consultants’ Meeting, December 8, 2004Roche Expert Investigator Forum, March 28 – 29, 2009LICENSURES AND CERTIFICATIONSCommonwealth of Pennsylvania #MD424900New York State License #161441-1State of Delaware #C1002992 9/1/87Cyprus #2114Greece #43/30-I-1976DEA # BM6509977LISTED Who’s is Who in the World, 1984Who’s is Who in Frontiers Science and Technology, 1984American Board of Medical Specialties, 1988New York State Physician Profile, 2002National Cancer Institute’s PDQ/ database, 1988LANGUAGES: English (Fluent), Greek (Fluent), French (Fair)OTHER INTERESTSPublic education in the areas of public health, cancer prevention and organization of support groups for cancer patients, AIDS patients, HIV carriers. Use of the medical profession in conflict resolution of International disputes and problems.PUBLIC EDUCATION/SERVICESMore than 100 monographs published in local newspapers and magazines on various medical issues ranging from tobacco smoking to bone marrow transplantation and cancer epidemiology in Cyprus (available on request)TV series: Consultant in the production of a 5 parts-program series on cancer education for the public, Cyprus Broadcasting Corporation, 1991More than 200 TV and radio talks and shows on oncological, hematological, nutritional and public health awareness issues in Cyprus, France and USAORIGINAL PAPERS1. Marcoullis, G. and Grasbeck, R.: Vitamin B12-binding proteins in human gastric mucosa. General pattern and demonstration of intrinsic factor isoproteins typical of mucosa. Scand. J. Clin. Lab. Invest. 35: 5-11, 19752. Grasbeck, R. and Marcoullis, G.: Studies on a fraction of human gastric mucosa containing intrinsic factor isoproteins typical of mucosa. Scand. J. Clin. Lab. Invest. 35: 13-18, 1975.3. Marcoullis, G. and Grasbeck, R.: Preliminary identification and characterization of antigen extracts from Onchocerca volvulus. Trop. Parasit. 27: 314-322, 1975.4. Marcoullis, G. and Grasbeck, R.: Solubilized intrinsic factor receptor from pig ileum and its characteristics. Biochim. Biophys. Acta 496: 36-51, 1977.5. Marcoullis, G, Grasbeck, R. and Salonen, E.-M.: Identification and characterization of intrinsic factor and cobalophilin from pig ileal and pyloric mucosa. Biochim Biophys. Acta 497: 663-672, 1977.6. Marcoullis, G.: Studies on the solubilized porcine ileal intrinsic factor receptor and on a 340, 000 dalton component binding vitamin B12. Biochim. Biophys. Acta 499, 373-381, 1977.7. Marcoullis, G. and Grasbeck, R.: Isolation of the ileal intrinsic factor receptor of the pig. Scand. J. Clin. Lab. Invest, 174 (Suppl.): 95, 1977.8. Marcouliis, G. et al: Parasite antigens. (Review) Bull. World Health Organiz. 52: 237-249, 1975. 9. Marcoullis, G. and Grasbeck, R.: Isolation of the porcine ileal intrinsic factor receptor by sequential affinity chromatography. Biochim. Biophys. Acta. 499: 309-314, 1977.10. Marcoullis," G.: Le facteur intrinseque et ses anticorps. In: Cours d’ immunohematologie et d' immunopathologie Medicales Institut Pasteur, 47: 361-394, 1977.11. Marcoullis, G., Salonen, E.-M. and Grasbeck, R.: Isolation of vitamin B12-binding proteins by combined immuno and affinity chromatography. Comparative studies on the isolated and unisolated proteins. Biochim. Biophys. Acta. 495: 336-348, 1978.12. Marcoullis G., Salonen, E. -M and Grasbeck, R.: Sequential affinity chromatography for the purification of antigens from Onchocerca volvulus adult worms. Trop. Parasit. 29: 3948, 1978.13. Marcoullis, G., Salonen, E.-M. and Grasbeck, R: Porcine serum cobalophilin and transcobalamin. Identification isolation and properties including electro focusing patterns. Biochim. Biophys. Acta. 534: 48-57, 1978.14. Marcoullis, G., Merivuori, H. and Grasbeck, R.: Comparative studies on intrinsic factor and cobalophilin in different parts of the gastrointestinal tract of the pig. Biochim. J. 173: 705-712. 1978.15. Marcoullis, G.: Soluble and membrane-bound proteins involved in vitamin B12 transport. Helsinki University, Finland, Academic Dissertation, 1978.16. Parmentier, Y., Nicolas, J.P. and Marcoullis. G.: Le transit intestinal de la vitamin B12 chez I’homme. Gastroent. Clin, Biol. 3, 79, 1979.17. Pamentier, Y., Marcoullis, G. and Nicolas, J.P.: Free intrinsic factor in the human intestinal juice. Ann. Nutr. Aliment 33: 287-288, 1979.18. Parmentier, Y., Marcoullis, G. and Nicolas, J.P.: Premiere mise en evidence et characterisation d'anticorps diriges contre les transporteurs de vitamin B12 chez I’homme. Ann. Nutr. Aliment, 33: 531-532, 1979.19. Marcoullis, G., Parmentier, Y. and Nicolas, J. -P.: Blocking and binding type antibodies against all major vitamin B12 binders in a pernicious anaemia serum. Brit. J. Haem 43: 15 -26, 1979.20. Parmentier, Y., Marcoullis, G. and Nicolas, J. -P.: The intraluminal transport of vitamin B12 and the exocrine pancreatic insufficiency. Proc. Soc. Exp. Biol. Med. 160: 396-400, 1979.21. Parmentier, Y., Marcoullis, G., Nicolas, J.-P. and Perrin, M-0. : The intraluminal phase of vitamin B12 transport in the human. In: Vitamin B12 (Zagalak, B and Friedrich, G., Editors) Walter de Gruyter. Berlin, New York 6: 803-807, 1979.22. Marcoullis, G., Rothenberg, S.P. and Labombardi, V.: Preparation and characterization of proteins in the alimentary tract of the dog which bind cobalamin and intrinsic factor. J. Biol. Chem. 255 (5): 1824-1829, 1979.23. Marcoullis, G., Parmentier, Y., Nicolas, J.P., Jimenez, M. and Gerald, P.: Cobalamin malabsorption due to non-degradation of R proteins in the human intestine. J. Clin. Invest. 66: 430-440;1980.24. Marcoullis, G., Nicolas, J.-P, Parmentier, Y., Jimenez M. and Gerard, P.: A derivative of R type cyanocobalamin binding proteins in the human intestine: A candidate antibacterial molecule. Biochim. Biophys. Acta. 633: 289-294, 1980.25. Nicolas, J.-P., Marcoullis. G.: Role des enzymes pancreatiques dans le transport intraliminal et l’absorption in leale de la vitamin B12. C.R. Soc. Biol. 174: 548-563, 1980.26. Nicolas, J.-P., Marcoullis. G., Parmentier, Y., Bigard, J.A., Gaucher, P., Jimenez, M. and Gerard, P.I The role of pancreatic enzymes in the intraluminal transport and ileal absorption of vitamin B12. Ann. Nutr. Al. 34 (3): 504-505, 1980.27. Nicolas, J.-P., Jimenez, M., Marcoullis, G and Parmentier,Y.: In vivo evidence that intrinsic factor cobalamin complex traverses the human intestine intact. Biochim. Biophys. Acta 675: 328-333, 1981.28. Marcoullis, G. and Rothenberg, S.P.: Intrinsic factor-mediated vitamin B12 absorption in the dog. Am. J. Physiol. 241: G294-G299, 1981.29. Marcoullis, G. Gueant, J. L. and Nicolas J.-P: Development of a radioimmunoassay specific for exocrine pancreatic insufficiency. Institute National Industriel, France, Patent No. 8120345, 1981.30. Marcoullis, G. and Rothenberg, S.P.: The functional activity of intrinsic factor measured using solubilized receptor protein. Clin. Chem. 28(8): 1794-1796, 1982.31. Rothenberg, S.P, Marcoullis, G. and Lader, E. : Antiserum to cyanocobalamin distinguishes physiologic cobalamins from cobinamide analog. Clin. Res. 30: A560, 1982.32. Marcoullis, G. and Rothenberg, S.P.: Isolation and characterization of two receptor species for intrinsic factor. Fed. Proc. 41: 1683, 1982.33. Rothenberg, S.P. and Marcoullis, G.: Measurement of cobalamin analogues in biological material by current techniques is erroneous, Clin. Chem.29 (8): 1557 –1576, 1983.34. Marcoullis, G. and Rothenberg, S.P.: Macromolecules in the assimilation and transport of cobalamin. In: Nutrition in Haematology. Contemporary Issues in Clinical Nutrition. Lidenbaum, editor, Churchill Livingstone Inc. New York. 5: 59-119, 1983.35. Marcoullis, G. and Nicolas, J.-P.: The interactions of cobalamin in the gastrointestinal tract. In: Progr. Gastroent. Glass, G.B.J., Sherlock, P. eds. Grune & Stratton, New York, Volume IV: 133 - 172, 1983.36. Rothenberg, S.P. and Marcoullis, G.: Development of a radioimmunoassay which distinguishes between cyanocobalamin and analogues. J. Lab. Clin. Invest. 103 (6): 959-972, 1984.37. Marcoullis, G. and Rothenberg, S.P.: Isolation and characterization of two species of receptor which bind intrinsic factor. Archives Biochem. Biophys. 235(2): 482 -492, 1984.38. Marcoullis, G., Gueant, J.L. and Nicolas, J.-P.: Radioimmunoassay assessing for exocrine pancreatic insufficiency, based on the differential enzymatic degradation of cobalamin-binding proteins. Clin. Chem. 32: 453-460, 1986.39. Ciobanu, N., Sparano, JA., Gucalp, R., Dutcher, J., Walewski, J., Marcoullis, G. and Wiernik, PH.: High dose Cisplatin (P), Carmustine (C) and Thiotepa (T) plus autologous bone marrow transplantation (ABMT) in advanced cancer. Proc. Am. Soc. Clin. Oncol. 12: 463, 199340. Marcoullis, G.: Medical Oncology in Cyprus; A Success story and triumph for cancer patients. Europ. Soc. Med. Oncol. Newsletter. 2: 6-8, 1995.41 Marcoullis, G., Treleaven, J. and Mehta. J.: Autologous Bone Marrow and Peripheral blood stem cell Transplantation in Hematological Malignancies: Current status. Med. Oncol. 1996, 12: 209 - 218.43. Dutcher JP, Novik Y, O’Boyle K, Marcoullis G, Secco C. and Wiernik PH: Twentieth century advances in drug therapy in oncology. Part I. J Clin Pharmacol 40:1007-1024,2000.44. Dutcher JP, Novik Y, O’Boyle K, Marcoullis G. Secco C. and Wiernik PH: Twentieth century Advances in drug therapy in oncology. Part II. J Clin Pharmacol 40:1079-1092, 200045. Marcoullis G., Abebe L. Jain D., Talusan R., Bhagwati N., and Wiernik P. H.: Microangiopathic hemolysis refractory to plasmapheresis responding to docetaxel and cisplatin. Medical Oncology 19:189-192, 200246. Marcoullis G: Contemporary Achievements in Cancer Treatment. The Cyprus Health Journal 2: 58-60, 201147. Dekatris M, Marcoullis G: Patient Expectations, Confusion and Desperation: Utilization or no utilization of Chemosensitivity and Chemoresistance Testing in Cancer Treatment. The Cyprus Health Journal 5: 16-17, 201148. Marcoullis G: Establishment of Medical Schools in Cyprus: Vision and Reality. The Cyprus Health Journal 5: 60-62, 201149 Marcoullis G: Hematologic Malignancies. In: The House Doctor. Life, Cyprus. 6: 21-24, 201150. Marcoullis G: Geriatric Oncology. The Cyprus Health Journal 10: 60-62, 201251 Μαρκουλλ?? Γ: Ιατρο? και Ιατρικ?? Σχολ?? στην Κ?προ κατ? την αρχαι?τητα και σ?μερα. Ιατρικ?? Κ?σμο?. 22: 22-24, 201652. Marcoullis G: The Basics of Leukemias: Causes, Epidemiology, Clinical Manifestations, Diagnosis & treatment: Cyprus Medical Journal 29 (2): 6-8, 2016ABSTRACTS1. Grasbeck, R. and Marcoullis, G.: Specific intrinsic factor isoproteins in human gastric mucosa. Abstracts of the European Society for Clinical Investigation. Rotterdam, April 25-27, 1974, p.116.2. Marcoullis, G. and Grasbeck, R.: Intrinsic factor receptor and vitamin B12-binding proteins in pig ileum. Abstracts of International Congress of Biochemistry. Hamburg, July 25-31, 1976, Abs No. 05-4-273.3. Nicolas, J.P., Parmentier, Y. and Marcoullis, G.: Free and biologically active intrinsic factor in the human intestinal juice. Abstracts of the X International Congress of Clinical Chemistry. P.71, Mexico, February 26-March 3, 1978.4. Marcoullis, G., Nicolas, J.P., Parmentier, Y. and Perrin, M.O.: Two antibody types against all vitamin B12-binders in a pernicious anaemia serum. Abstracts of XVII International Congress of Haematology. P. 750, Paris, July, 1978, Paris, Abs No 59/1181-41.5. Marcoullis, G. and Grasbeck, R.: Isolation of the intrinsic factor receptor of the pig. Abstracts of XVI Nordiska Kongressen for Klinisk Fysiologi. Oulu, Finland, June 28-30, 1977, Abs No. 119.6. Parmentier, Y., Marcoullis, G. and Nicolas, J.P.: Miss en 'evidence d'anticorps des deux types diriges contre I'ensemble des transporteurs de vitamin B12 chez un sujet porteur d'anemie de Biermer. In the Abstracts of the Reunion Francophons sur le theme "Les Immunoglobulines". Bandol, France, August 1979.7. Nicolas, J.P., Marcoullis, G. Parmentier, Y., Bigard, M.A., Gaucher, P., Jimenez, M. and Gerard,P.: Le role des enzymes pancreatiques dans le transport intraluminal et le absorption ileale de lavitamin B12 (Cbl) . Societe Francaise de Nutrition-Lyon-janvier, 1980.8. Marcoullis, G., Rothenberg, S.P. and Jimenez, M.: Conformational changes of the receptormolecule in its interaction with intrinsic factor. 65th Annual Meeting FASEB. Georgia, April 12-17, 1981.9. Rothenberg, S.P, Marcoullis, G. and Lader, E. : Antiserum to cyanocobalamin distinguishes physiologic cobalamins from cobinamide analog. Clin. Res. 30: A560, 1982.10. Marcoullis, G. and Rothenberg, S.P.: Isolation and characterization of two receptor species for intrinsic factor. Fed. Proc. 41: 1683, 1982.9. Rothenberg, S.P., Marcoullis, G. and Schwarz, S.: Human serum contains cobinamide whichfalsely elevates the cobalamin by R-protein radioassay. Annual Meeting of the American Societyof Haematology, San Francisco, December 1983.10. Ciobanu, N., Sparano, JA., Gucalp, R., Dutcher, J., Walewski, J., Marcoullis, G. and Wiernik, PH.: High dose Cisplatin (P), Carmustine (C) and Thiotepa (T) plus autologous bone marrow transplantation (ABMT) in advanced cancer. Proc. Am. Soc. Clin. Oncol. 12: 463, 1993NOTE: For more detailed or additional information, please see below “Appendix to the CV of George P. Marcoullis, MD, PhD”, on page 12, Appendix to the CV of George P. Marcoullis, MD, PhDTEACHING & EDUCATIONAL ACTIVITIES:OTHER AWARDSEuropean School of Oncology; “For contribution in the scientific development of the School”; 1997CURRICULA & SEMINARSChairperson and Member of the Organizing Committee, Ministry of Health Cyprus: Ημερ?δα για ευκαιρ?ε? ερευνητικ?? δραστηρι?τητα? ειδικ?ν και ειδικευομ?νων ιατρ?ν στα δημ?σια νοσηλευτ?ρια, Nicosia General Hospital, June 7, 2016Chairperson & President Organizing Committee: European University Cyprus International Advisory Board Meeting, February 12, 2016President Organizing Committee: Cyprus Annual Medical Students Meeting-European University Cyprus, February 13, 2016Chairperson: Second Pancyprian Hematology Meeting, Cyprus Society of Hematology, January 21-22, 2012Organizing Committee-member: 2008-New Light Cancer Seminar, Anti-cancer Society of Cyprus, October 31 – November 2, 2008Chairperson: Round Table Discussion/Public Session: In “2008-New Light Cancer Seminar”, Anti-cancer Society of Cyprus Annual Meeting, October 31 – November 2, 2008Chairperson: In “Multiple Myeloma and Paraproteinemias”; Departments of “Renal Diseases” and “Haematology”, Nicosia General Hospital, Cyprus; February 23, 2006Chairperson: In the “Lymphoma Sessions”, European Society of Medical Oncology, 23rd Congress, November 6 -10, 1998Chairperson: in the “Leukemias and Myeloma Sessions”, European Society of Medical Oncology, 21st Congress, November 1- 5, 1996Organizing Committee- Member: 1996-European Group for Breast Cancer Screening, September 27 - 28, 1996Chairman: In “Cancer, Recent Developments in Diagnosis and Treatment”; The Cyprus Anti-Cancer Society Symposium in Memory of Marianna Lordos, February 2-4, 1996Organizing Committee-Member and Chairman: Seminar on High Dose Chemotherapy and Bone Marrow Transplant; The Cyprus Anti-Cancer Society Annual Seminar, Nicosia, January 12, 1995Chairperson: In Seminar “Hematopoietic Growth Factors and Biological Response Modifiers”, European School of Oncology, December 10-13, 1992Organizing Committee-Member and Chairman: Recent Advances in the Prevention and Management of: Gynaecological Cancer, Urological Cancer, Lung Cancer; The Cyprus Anti-Cancer Society Annual Seminar, Limassol, November 24-25, 1990Organizing Committee-Member and Chairman: Recent Advances in Diagnosis and Treatment of Lymphomas, Leukemias, Gastrointestinal Cancer, Thyroid Cancer; The Cyprus Anti-Cancer Society Annual Seminar, Limassol, February 10-11, 1990Organizing Committee-Member: Planning and Development of “The Tumor Registry of Cyprus”, 1991-1998SERVICEEditorial Board, Cyprus Health Journal, 2010 – 2012Cancer Investigation, Reviewer, 2002Board Member: European Society of Medical Oncology, National Representatives Committee, 1992 -1999; Re-elected: January 2006 - 2013Project Director: Planning, Fund Raising and Development of a “Day Center for Cancer patients” (The Cyprus Anti-Cancer Society) in Cyprus, 1996 – 1998Board of Directors- Member: Cancer Society of Cyprus, 1991 – 1998Cyprus Anti-Cancer Society, Medical Committee-member, November 2005 - 2010Board Member: European Society of Medical Oncology, National Representatives Committee, 2006- Cyprus Society of Oncology, Vice President, April 2007 – INVITED SPEAKER & LECTURESManagement of Leukemias in the Elderly: “Cyprus Society of Allergology and Immunology” Lectures,October 24, 1990Everything you Want to Know about AIDS, organized by: Endoscopy Journal; Cyprus College May, 7,1991Transport Mechanisms of Hematinic Factors – Cyanocobalamin: Ist International HematologySymposium, BIO-TRANS Medical Institute, Nicosia, June 5-6, 1992Breast Cancer-Prevention and Treatment: in “Study Day on Family Planning Related Issues, Part II”,Nursing Public School Lectures, Nicosia, June 17, 1992Systemic Therapies-Autologous Bone Marrow Stem Cell Transplantation: in “Breast Cancer- Present and Future”, Hellenic Association for the Study of Breast Cancer, November 26-27, 1992Vitamin B12 Malabsorption in Exocrine Pancreatic Dysfunction: 11th Pancyprian Medical AssociationCongress, November, 6-7, 1993Bone Marrow Transplantation in Malignant Neoplasias in Refractoriness and in Remission: NicosiaMedical Association “Hippocrates” Annual Meeting, January 15-16, 1994Bone Marrow Transplantation in Refractory and Responding Leukemias, Lymphomas and Solid Tumors: International Oncologists Meeting, Limassol, March 22-26, 1994Breast Cancer: Chemotherapy and Bone Marrow Stem Cell Transplantation: Apollonion Private Hospital Monthly Seminars, Nicosia, April 21, 1994Bone Marrow Transplantation in the Treatment of Malignancies: Limassol Medical Association, TheHellenic Medical Society and Georgetown University “Clinical Seminar”, Limassol, June 30- July 2, 1995Breast Cancer-Prevention and Treatment: Nursing Public School Lectures, Nicosia, November 10, 1995The Role of High Dose Chemotherapy and Bone Marrow Transplant or Peripheral Stem Cell Replacement in the Management of Breast Cancer: The 4th Cyprus Anti-Cancer Society Symposium in Memory of Marianna Lordos, February 2-4, 1996Testicular Tumors; 1998 – World Hellenic Biomedical Conference, New York, December 5-6, 1998Management of Advanced Non-seminomatous Germ Cell Cancer: European School of Oncology Seminar, Cyprus, 1998Cancer Prevention; Nicosia Medical Association Conference, Cyprus, April 24 – 25, 1999Reducing your Cancer Risk; Women’s Health & Wellness Conference: Hellenic American Women’sCouncil, Washington D.C., May 10, 2003Meet the Doctor: Latest Treatments in Blood Cancers: The Leukemia & Lymphoma Society, Erie PA,April 27, 2005Current Management of Haematological Malignancies: 8th Marianna Lordos Seminar; Nicosia, Cyprus; February 10-12, 2006Advances/Developments in Current Treatment of Cancer: Cyprus Free University; Nicosia, Cyprus;January 11, 2006Advances/Developments in Current Treatment of Cancer: Limassol Free University; Evagoras LanitisCultural Center, Limassol, Cyprus; January 30, 2006Myoskeletal Manifestations in Malignant Diseases; 6th Annual Meeting of the Cyprus Orthopedics and Trauma Surgical Society, Nicosia, Cyprus; April 15, 2006Dose Dense Chemotherapy: Achievements; International Forum for the Study of Familial and Early Breast Cancer, Nicosia, Cyprus, October, 18-21, 2007Private Medical Schools: Infrastructure, Perspectives, Goals. Plans and Projects; 4th World Congress of Hellenic and Cypriot Medical & Biosciences Network, Paphos, Cyprus, April 24- 27, 2013Σ?γχρονα Επιτε?γματα στη Θεραπε?α τη? Χρ?νια? Μυελογενο?? Λευχαιμ?α?: 35ο Δι?μερο Ιατρικ? Συν?δριο Ιατρικο? Συλλ?γου Λεμεσο?; Λεμεσ??, 28-29 Μαρτ?ου 2015Prostate Cancer: Biochemical Relapse and Chemotherapy; Europa Uomo Cyprus Conference: Prostate Cancer, Nicosia University School of Medicine, Cyprus, February 25, 2017GRAND ROUNDS/TEACHING CONFERENCESHematologic Malignancies/ Treatment with High Dose Chemotherapy and Blood and Marrow Stem Cell Transplantation; Visiting Professor Lecture, WMHS Regional Cancer Center, March 5, 2004High Dose Chemotherapy and Stem Cell Transplantation; Oncology Grand Rounds, New York MedicalCollege, January 29, 2004Oncological Emergencies; Oncology Grand Rounds, New York Medical College, September 4, 2003Megaloblastic Anemias; Hematology/Oncology Residents Lectures, New York Medical College, December 13, 2002Microcytic Anemias; Medical Student Lectures, New York Medical College, December 6, 2002Acute Leukemias; Hematology/Oncology Residents Lectures, Our Lady of Mercy Medical Center, May 24, 2002Megaloblastic Anemias; Hematology/Oncology Residents Lectures, Our Lady of Mercy Medical Center, February 1, 2002Autologous Stem Cell Transplantation in Hematologic Malignancies; Oncology Grand Rounds, Our Lady of Mercy Medical Center, September 20, 2001The Anemias; Hematology/Oncology Residents Lecture, Our Lady of Mercy Medical Center, September 7, 2001High Dose Chemotherapy and Stem Cell Transplantation; Internal Medicine Ground Rounds, D’ursoHospital, June 11, 2001Acute Myelogenous Leukemia; Oncology Grand Rounds, Our Lady of Mercy Medical Center, March 15, 2001Diagnosis and Treatment of Acute Myelogenous Leukemia; Oncology Grand Rounds, Our Lady of Mercy Medical Center, February 22, 2001Autologous Stem Cell Transplantation; Internal Medicine Grand Rounds, Our Lady of Mercy MedicalCenter, January 31, 2001Bone Marrow Transplantation; Hematology/Oncology Residents Lectures, Our Lady of Mercy Medical Center, December 22, 2000Bone Marrow Transplantation; Oncology Grand Rounds, Our Lady of Mercy Medical Center, December 14, 2000Non-Hodgkin Lymphoma; Oncology Grand Rounds, Our Lady of Mercy Medical Center, November 2,2000Diagnosis and Management of Anemia Patients; Medical Students Lectures, Our Lady of Mercy Medical Center, October 30, 2000Case Management; Hematology/Oncology Residents Lectures, Our Lady of Mercy Medical Center,October 27, 2000Non-Hodgkin Lymphoma; Oncology Grand Rounds, Our Lady of Mercy Medical Center, October, 12 2000The Anemias; Hematology/Oncology Residents Lectures, Our Lady of Mercy Medical Center, September 22, 2000Coagulation; Hematology/Oncology Residents Lectures, Our Lady of Mercy Medical Center, January 28, 2000The Anemias; Hematology/ Oncology Resident Lectures, Our Lady of Mercy Medical Center, December 10, 1999Lymphomas; Oncology/Hematology Residents Lectures, Our Lady of Mercy Medical Center, November 26, 1999OTHER TEACHINGAcademic years, September-June, 2016-2019- ; Nicosia University School of Medicine: Medicine and Surgery Students: Clinical Training, 9 ? hrs/weekOctober 2007-January 2008 and 2009; Frederick University Cyprus:-Nursing School Students: Anatomy, Histology and Physiology, 4 hrs/week-September 1999 –October 2004; Our Lady of Mercy Medical Center: Medical residents, students and hematology/oncology fellows: Attending Ward Rounds, 12 hrs/wk for two months per year-Medical residents, and fellows; Hematology and Oncology consultations, 10 hrs/wk for 4 months per year-Medical students and residents: Teaching rounds and supervision, 6 hour/ week-Medical residents, fellows and physicians: Tumour Board Conferences, 1 hour/week-Medical residents, fellows and physicians: Blood and bone marrow film preparation andexamination/interpretation, 2 hours/weekJanuary 1996 – September 1999 (Evangelistria Medical Center and Public Hospitals, Cyprus):-Cancer prevention, 1 hour/ month-Cancer; Early diagnosis, 1 hour/month-Introduction to cancer treatment, 1 hour/month-Bone marrow transplantation, 1 hour/month-Blood and bone marrow films preparation and examination, 5 hours/week-Anemias, 1 hour/semester-Coagulopathies, 1 hour/semester-Thrombostasis abnormalities, 1 hour/semesterORGANIZATION & TEACHING IN WORKSHOPS/LABORATORY CLASSES:Accidents, Complications and side effects involving cytotoxic agents; A Workshopfor Nurses; Evangelistria Private Hospital and Hippocrateon Private Hospital, Cyprus, 1991 – 1998, 2006, once per annumAnatomy-Laboratory for Nursing Students: Frederick University Cyprus, October, 2007-January, 2008 and 2009, 2 hrs/wkΕνδο?πηρεσιακ? Επιμ?ρφωση Επαγγελματι?ν Υγε?α? για Θ?ματα Β?α? στην Οικογ?νεια, Συζ?τηση Στρογγυλ?? Τρ?πεζα?: Ερευνητικ? Κ?ντρο Frederick : 5, 12,19, 26 Ιουν?ου 2008Στ?σει? και Αντιλ?ψει? των Επαγγελματι?ν Υγε?α? για τη Β?α στην Οικογ?νεια, Συζ?τηση Στρογγυλ?? Τρ?πεζα?: Ερευνητικ? Κ?ντρο Frederick : 5, 12,19, 26 Ιουν?ου 2008CONTINUING MEDICAL EDUCATIONJune 21st, 2019: Symposium on Cannabinoids in Research and Patient Care, EvexoApril 5th, 2019: Recent Advances in Cancer Diagnosis and Treatment, Karaiskakio FoundtionMarch 26-27, 2019: Highlights of ASH, American Society of Hematology, Athens, Greece, CME Credit 26 hrsJanuary 26-27, 2019: 5th Multidisciplinary Conference, Cyprus Society of Haematology, Nicosia, CyprusMay 8-9, 2018: Myeloproliferative Neoplasms Preceptorship, Guy’s Hospital, LondonApril 25, 2018: Σ?γχρονε? Εξελ?ξει? και Πρ?τυπα Ποι?τητα? στη Φαρμακοθεραπε?α Καρκινοπαθ?ν Ασθεν?ν, Frederic University CyprusApril 21st, 2018: Contemporary Treatment Options for Her2- Advance Breast Cancer, Novartis Oncology, Limassol, CyprusFebruary 28, 2018: Relapsed/Refractory CLL, Stavros Niarchos Foundation, June 19, 2017: Developments in Advanced Breast Cancer, Novartis, Nicosia, CyprusFebruary 11, 2017: 4th Multidisciplinary Conference, Cyprus Society of Haematology, Nicosia, CyprusMay 5-7, 2016: European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Imedex, Zagreb, CroatiaNovember 13–15, 2014: 25ο Πανελλ?νιο Αιματολογικ? Συν?δριο, Ελληνικ? Αιματολογικ? Εταιρε?α, Θεσσαλον?κη, Ελλ?δα June 14, 2014: Οδοντοστοματολογικ? Προβλ?ματα στην Καθημεριν? πρ?ξη; School of Medicine, European University CyprusMarch 25, 2014: Laureate Code of Conduct and Ethics Course; LRN Legal Compliance and Ethics Center, Laureate Education Inc.March 7-9, 2014: Global Opinion Leader Summit (MPN GOLS) “Clinical Challenges in the Management of Patients with MPN” & “Advances in the Management of CML: The Road Ahead” Amsterdam, the Netherlands. CPD credit 12 hrsJanuary 18-19, 2014: 3rd Hematology Meeting, Cyprus Society of Hematology, Limassol, Cyprus. Credit: 6 hrsSeptember 27- October 10, 2013: 17th ECCO-38th ESMO-32nd ESTRO European Cancer Congress,Amsterdam, the Netherlands. CME credit: 24 hrsJune 13-16, 2013: 18th Congress of the European Hematology Association, Stockholm, Sweden. CMEcredit: 21.00 hrsMarch 9, 2013: Thromboembolic Disease, Cyprus Society of Hematology, Nicosia, Cyprus. CME credit 4 hrsJune 14-17, 2012: 17th Congress of the European Hematology Association, Amsterdam, the Nethrlands. CME credit: 21.25 hrsJanuary 21-22, 2012: 2nd Hematology Meeting, Cyprus Society of Hematology, Nicosia, Cyprus. credit: 6 hrsSeptember 23-27, 2011: European Multidisciplinary Cancer Congress, Stockholm, Sweden. Credit: 22 hrsJuly 15-16, 2011: 1st Hematology Meeting, Cyprus Society of Hematology, Cyprus. Credit: 6 hrsJuly 2-3, 2011: Hematology Meeting, Cyprus Society of Hematology, CyprusJune 25, 2011: Focus on Hepatocellular Cancer, Cyprus Oncology Society, CyprusJune 9-13, 2011: 16th Congress of the European Hematology Association, London, Great Britain. CME credit: 21.25 hrsSeptember 10-11, 2010: Polythematic Symposium in Hematology, Cyprus Society of Hematology, Nicosia, Cyprus. credit: 6 hrsJune 10-13, 2010: 15th Congress of the European Hematology Association, Barcelona, Spain. CME credit: 18.25 hrsMarch 25-29, 2010: MabThera Expert Meeting, Prague, Czech RepublicDecember 5-8, 2009; 51st ASH Annual Meeting, New Orleans, Louisiana. Category 1 credit: 37 hrsJune 4-7, 2009; 14th Congress of the European Hematology Association. Berlin, Germany. CME credit: 20.25 hrsMarch 13, 2009; 10th Marianna Lordos Lecture, Nicosia, Cyprus. CME point 1September 12 – 16, 2008; 33rd ESMO Congress, Stockholm, Sweden. Category 1 credit: 24 hrsMay 30-June 3, 2008; 44th ASCO Annual Meeting, Chicago, IL. Category 1 credit: 30.75 hrsApril 15-19, 2008; 6th European Breast Cancer Conference, Berlin. Category 1 credit: 16 hrsJuly 5-8, 2007; European Society of Medical Oncology Conference Lugano. Lugano, Switzerland.Category 1 credit: 18 hrsJune 7-10, 2007; !2th Congress of the European Hematology Association. Vienna, Austria. CME credit:20.25 hrsFebruary 23-25, 2007; 3rd European Congress on Hematologic Malignancies from Clinical Science toClinical Practice. Athens, Greece. European external CME credit: 12 hrsSeptember 29-October 3, 2006; European Society for Medical Oncology 31st Congress, Istanbul, Turkey. Category 1 credit: 24 hrsSeptember 22-23, 2006; Follicular Lymphomas, Chronic Lymphocytic Leukemia and Marginal ZoneLymphomas. Hellenic Hematology Society, Athens GreeceJune 28-July 1, 2006; 8th World Congress on Gastrointestinal Cancer, Barcelona, Spain. Category 1 credit: 23.00 hrsJune 15-18, 2006; European Hematology Association 11th Congress, Amsterdam, Netherlands. Category 1 credit: 17.75 hrsFebruary 23, 2006; “Multiple Myeloma and Paraproteinemias”; Departments of “Renal Diseases” and “Haematology”, Nicosia General Hospital, Cyprus. Credit: 5 hrsFebruary 10-12, 2006; 8th Marianna Lordos Seminar, Larnaka, CyprusDecember 10-13, 2005; 47th ASH Annual Meeting, Atlanta, Georgia. Category 1 credit: 33.75 hrsOctober 30-November 3, 2005; 13th Bi-annual Meeting of Federation of European Cancer Societies, Paris, France. Category 1 credit: 21 hrsJune 24-25, 2005; ASCO Highlights/NOCR. Category 1 credit: 6 hrsJanuary 28, 2005; Combined Results of Two AI Switching Trials. University of Alabama School ofMedicine. Category 1 credit: 0.25 hrNovember 24, 2004; Coumadin Venous Thromboembolism Patient Safety. Hamot Medical Center.Category 1 credit: 1 hrJuly 2, 2003-June 30, 2004; Current Concepts in Cancer; New York Medical College. Category 1 credit: 20 hrsJuly 10, 2003-June 24, 2004; Leukemia and Lymphoma Cases; New York Medical College. Category 1credit: 26 hrsJuly 10, 2003-June 24, 2004; Oncology Grand Rounds; New York Medical Oncology. Category 1 credit: 9 hrsJuly 26, 2003-June 23, 2004; Advances in Medicine Grand Rounds; New York Medival College. Category 1 credit:15 hrsOctober 14,2003-May 11, 2004; Oncology Basic Science Lectures; New York Medical College. Category 1 credit: 4 hrsJune 4-8, 2004; 40th ASCO Annual Meeting, New Orleans. Category I credit: 25.25 hrsMay 14, 2004; Proteasome Inhibition/A novel Approach to the Treatment of Multiple Myeloma;Postgraduate Institute for Medicine. Category 1 credit: 2 hrsFebruary 13-17, 2004; Tandem BMT Meetings; Medical College of Wisconsin. Estimated Category 1credit: 39.75 hrsDecember 23, 2003; Management of Thromboembolism in Cancer Patients; Medical Education Resources. Category 1 credit: 1 hrDecember 4, 2003; Lectures on Toxicities and Chemotherapy: A Physician’s Perspective; MedicalEducation Group LLC. Category 1 credit: 1 hrJuly 17, 2002-June 11, 2003; Advances in Medicine; New York Medical College. Category 1 credit: 14 hrsMay 31-June 3, 2003; 39th ASCO Annual Meeting, Chicago. Category 1 credit: 27 hrsMay 30th 2003; ASCO 2003 Educational Symposia: Principles of Molecular Biology, Chicago. Catecory 1 credit; 4 hrsJanuary 8, 2003-June 25, 2003; Current Concepts in Cancer; New York Medical College. Category 1credit: 22 hrsOctober 12-16, 2002; Medical Oncology Board Review; The George Washington University. Category 1 credit: 38 hrsSeptember 10, 2002-May13, 2003; Basic Science Lectures; New York Medical College. Category 1 credit: 2 hrsJuly 18, 2002-May 22, 2003: Oncology Grand Rounds; New York Medical College. Category 1credit: 11 hrsJuly 11, 2002-June 26, 2003; Leukemia and Lymphoma Cases; New York Medical College. Category 1credit: 28 hrsMarch 12, 2002; First Line Therapy for Colorectal Cancer: Where Are We Now? University of SouthDakota School of Medicine. Category 1 credit: 1 hrFebruary 22-26, 2002; 2002 Tandem BMT Meetings; Medical College of Wisconsin. Category 1 credit:39.75 hrsFebruary 19, 2002; Osteoarthritis/ Myofascial Pain, St. Francis Hospital, NY. Category 1 credit:1 hrFebruary 12, 2002; Recent Developments and Future Directions in the Treatment of Renal Cell Carcinoma (telesession), Center for Biomedical Continuing Education. Category 1 credit: 1 hrFebruary 11, 2002; Recent Developments and Future Directions in the Treatment of MyelodysplasticSyndromes, (telesession), Center for Biomedical Continuing Education. Category 1 Credit: 1 hrJanuary 24, 2002; Congestive Heart Failure, St. Francis Hospital, NY. Category 1 credit: 1 hrJanuary 9-December 18, 2002; Current Concepts in Cancer, New York Medical College. Catecory 1 credit: 25 hrsJanuary 3, 2002; Combination Therapy for Breast Cancer, The Academy of Medicine of New Jersey.Category 1 credit: 1.5 hrDecember 8-11, 2001; 43rd Annual Meeting of the American Society of Hematology, Orlando, Florida. Category 1 credit: 28 hrsDecember 7, 2001; Treatment and Management of Acute Myeloid Leukemia, The University ofWashington School of Medicine. Category 1 credit: 3 hrsDecember 5, 2001; Platinums: New Data in the Treatment of Breast Cancer, The Academy of Medicine of New Jersey, Category 1 credit: 1 hrNovember 28, 2001; Geriatric Gastroenterology Seminar, Academy of Medicine of Queens County.Category 1 credit: 3 hrsNovember 20, 2002; Multiple Myeloma Chemotherapy, University of Wisconcin Medical School,Category 1 Credit: 1 hrNovember 18, 2001; Video Medical Oncology Board Review; The George Washington University.Category 1 credit: 38 hrsNovember 13, 2001- June, 11, 2002; Basic Science Lectures. New York Medical College. Category 1 credit: 3 hrsOctober 13, 2001; Medical Oncology Board Review; George Washington University. Category 1 credit: 37 hrsSeptember 21, 2001; Ninth Annual Progress in Hematologic Malignancies and Bone MarrowTransplantation, John Hopkins, Baltimore. Category 1 credit: 7 hrsSeptember 6, 2001-June 27, 2002; Leukemia and Lymphoma Cases; New York Medical College. Category 1 credit: 30 hrsAugust 28, 2001; Pathophysiology and Management of Chemotherapy-induced Diarrhea in the Oncology Practice, Medical Education Resources. Category 1 credit: 1 hrJuly 19, 2001 – June 27, 2002; Oncology Grand Rounds, New York Medical College. Category 1 Credit:11 hrsJuly 18, 2001- June 17, 2002; Advances in Medicine, New York Medical College. Category 1 credit: 18 hrsMay 30, 2001; Geriatric Medicine for Primary Care, New York Medical College. Category 1credit: 3 hrsMarch 1 – June 28, 2001; Oncology Grand Rounds, New York Medical College. Category 1 credit: 10 hrs 2001 Teleconference; Trends in Polyanalgesia, American Academy of Family Physicians. Category 1 credit: 1 hrMay 10 – 15, 2001; 37th Annual Meeting of the American Society of Clinical Oncology, San Francisco.Category 1 credit: 25.63 hrsApril 19, 2001; Focus on tumor lysis syndrome. Category 1 credit: 1 hrJanuary 11,2001; National Initiative in Continuing Medical Education, Cancer Initiative. Category 1credit: 1 hrJanuary 10, 2001 – December 5, 2001; New York Medical College, Current Concepts in Cancer.Category 1 credit: 28 hrsJanuary 3, 2001- June 13, 2001; Advances in Medicine, New York Medical College. Category 1 credit: 12 hrsJanuary 5, 2000 – December 27, 2000; New York Medical College, Current Concepts in Cancer. Category 1 credit: 25 hrsNovember 14, 2000; Setting a new standard in the management of Advanced Breast Cancer. Category 1 credit: 1 hrOctober 24, 2000; Dendritic cells: pacemakers of the immune system. Category 1 credit: 1 hrSeptember 15, 2000; Hematologic Malignancies & BMT, Johns Hopkins, Baltimore. Category 1 credit:6.5 hrsSeptember 14, 2000; Gene therapy involving immune modulation. Category 1 credit: 1 hrMay 20 – 23, 2000; 36th Annual Meeting of the American Society of Clinical Oncology, New Orleans.Category 1 credit: 30.5 hrsMay 19, 2000; Medical informatics and Oncology practice educational symposium, ASCO-2000Meeting, New Orleans. Category 1 credit: 4 hrsMarch 31, 2000; New Millennium Strategies and Developments in Multimodality Cancer Therapy, New York Medical College. Category 1 credit: 7 hrsJanuary 6, 1999- December 15, 1999; Advances in Medicine, New York Medical College. Category 1credit: 1 hrJune 2-5, 1999; VII International Conference on Malignant Lymphoma, Lugano, Switzerland. Estimated number of credits: 20 hrsMay 15-18, 1999; 35th Annual Meeting of the American Society of Clinical Oncology, Atlanta, Georgia. Category 1 credit: 31.5 hrsMay 14, 1999: The Cancer Genetics Satellite Symposium, American Society of Clinical Oncology,Atlanta, Georgia. Category 1 credit: 5.5 hrsJanuary 6, 1999-December 29, 1999; Current Concepts in Cancer, New York Medical College. Category 1 credit: 10 hrsNovember 6 –10, 1998; 23rd ESMO Congress, Athens, Greece. ESMO-MORA Category 1 credit: 25 hrsJuly 4 - 8 1998; 27th Congress of the International Society of Hematology and the 3rd Congress of the European Hematology Association, Amsterdam, the Netherlands. Estimated CME credit: 20hrsMay 15-19, 1998; 34th Annual Meeting of the American Society of Clinical Oncology and SatelliteSymposia, Los Angeles, USA. Category 1 credit: 21 hrsMarch 15, 1998; Case studies in the Management of Chemotherapy-lnduced Thrombocytopenia, SanAntonio, Texas, USA. Category 1 credit: 1.5 hrsMarch 14-17, 1998, International Symposium of Supportive Care in Cancer, San Antonio, Texas.Category 1 credit: 23 hrs1997 European School of Gynecological Cancer: Postgraduate and Training Course, Nicosia, Cyprus.Estimated Credit: 20hrsNovember 3-5, 1996; 21st European Society of Medical Oncology Congress, Vienna, Austria. ESMOMORA Category 1 credit: 25 hrsSeptember 27-28, 1996- Annual Meeting of the European Group of Breast Cancer, Cyprus, CMEcredit: 11 hr ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download